Literature DB >> 2349162

Hyperostosis frontalis interna, acromegaly and hyperprolactinaemia.

J D Fulton1, J Shand, D Ritchie, J McGhee.   

Abstract

The association between hyperostosis frontalis interna (HFI), acromegaly and hyperprolactinaemia was investigated. Thirty six acromegalic patients, of whom 19 had hyperprolactinaemia, were compared with 36 randomly-selected, age-sex matched controls. There was a higher prevalence of HFI in the skull X-rays of the acromegalic cohort (P = 0.0002) when compared to the control group. This difference was apparent in both men (P = 0.01) and women (P = 0.01). Acromegalic patients with hyperprolactinaemia also expressed HFI in a higher proportion of individuals than the control group (P = 0.0001). Intra- and interobserver variability was assessed and concordance with 100% and 97% in the moderate and severe HFI sub-groups. The following sub-group analysis was undertaken: acromegalics and those acromegalics with hyperprolactinaemia were compared with the controls and a highly significant distinction was confirmed (P = 0.0007 and P = 0.00001 respectively). A relationship between HFI severity and the patient's age was noted in both male and female acromegalics. Also, the severity of HFI appeared related to disease duration in female acromegalics. The cause of HFI remains unknown but appears to be strongly associated with acromegaly, particularly in the presence of co-existent hyperprolactinaemia. The association may have symptomatic significance and the presence of HFI should be confirmed or refuted in all patients with acromegaly.

Entities:  

Mesh:

Year:  1990        PMID: 2349162      PMCID: PMC2429375          DOI: 10.1136/pgmj.66.771.16

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Hyperostosis cranii in a normal population.

Authors:  A SALMI; A VOUTILAINEN; I R HOLSTI; C E UNNERUS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-06

2.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Hyperostosis frontalis, galactorrhoea/hyperprolactinaemia, and Morgagni-Stewart-Morel syndrome.

Authors:  M Pawlikowski; J Komorowski
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

Review 4.  Pituitary tumors secreting growth hormone and prolactin.

Authors:  S Melmed; G D Braunstein; R J Chang; D P Becker
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

5.  The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours.

Authors:  A Jadresic; L M Banks; D F Child; L Diamant; F H Doyle; T R Fraser; G F Joplin
Journal:  Q J Med       Date:  1982

6.  New bone formation in acromegaly: pathogenetic implications for diffuse idiopathic skeletal hyperostosis.

Authors:  G O Littlejohn; S Hall; C A Brand; A Davidson
Journal:  Clin Exp Rheumatol       Date:  1986 Apr-Jun       Impact factor: 4.473

7.  Plasma growth hormone level in the Morgagni-Stewart-Morel syndrome.

Authors:  D Koev; S Milanov; L Koeva; V Sirakova
Journal:  Endocrinologie       Date:  1978 Jan-Mar
  7 in total
  2 in total

1.  Frontal cortex dysfunction due to extensive hyperostosis frontalis interna.

Authors:  Thomas Gilbert; Sabrina Ait; Floriane Delphin; Emmanuel Raharisondraibe; Marc Bonnefoy
Journal:  BMJ Case Rep       Date:  2012-01-10

2.  Frequency of hyperostosis frontalis interna in patients with active acromegaly: is there a possible role of GH excess or hyperprolactinemia in its etiopathogenesis?

Authors:  Ummu Mutlu; Ozge Telci Caklili; Mehmet Barburoglu; Sema Yarman
Journal:  Hormones (Athens)       Date:  2022-10-12       Impact factor: 3.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.